AtriCure, Inc. Forecast, price target & analysts
AtriCure, Inc. Target price 2026 - Analyst rating & recommendation
AtriCure, Inc. Classifications & Recommendation
AtriCure, Inc. Price Target
| Target Price | $52.02 |
| Price | $59.12 |
| Deviation |
12.01%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target AtriCure, Inc. 2027 .
The average AtriCure, Inc. target price is $52.02.
This is
12.01%
register free of charge
$63.00
6.56%
register free of charge
$43.43
26.54%
register free of charge
|
|
| A rating was issued by 16 analysts: 13 Analysts recommend AtriCure, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AtriCure, Inc. stock has an average upside potential 2027 of
12.01%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 534.53 | 618.34 |
| 14.88% | 15.68% | |
| EBITDA Margin | -1.20% | 14.43% |
| 84.92% | 1,303.32% | |
| Net Margin | -2.14% | 1.21% |
| 77.70% | 156.49% |
12 Analysts have issued a sales forecast AtriCure, Inc. 2026 . The average AtriCure, Inc. sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an AtriCure, Inc. EBITDA forecast 2026. The average AtriCure, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 AtriCure, Inc. Analysts have issued a net profit forecast 2026. The average AtriCure, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.24 | 0.15 |
| 74.74% | 162.50% | |
| P/E | 389.03 | |
| EV/Sales | 4.54 |
12 Analysts have issued a AtriCure, Inc. forecast for earnings per share. The average AtriCure, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current AtriCure, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Sep 02 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 27 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 24 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Jul 28 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 06 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Feb 18 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Feb 18 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Sep 02 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 27 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 24 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Jul 28 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 06 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Feb 18 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Feb 18 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
